List view / Grid view
The discovery that HIV capsids are importin-like transporters could be exploited for improved AIDS therapies.
The new findings could help preventive and therapeutic HIV vaccine design and development, and HIV immunotherapy approaches.
New Salk Institute, US, research could lead to the development of new HIV therapeutics that overcome resistance to existing drugs.
An experimental HIV vaccine, delivered as increasing doses over several days, led to long-lasting and diverse antibody production in monkeys.
A new computer-based approach could help clinicians select the best combinations of broadly neutralising antibodies to treat HIV based on the virus’ genetics, while minimising the risk of the virus escaping treatment.
Researchers have discovered how immune system dendritic cells are key to maintaining and regulating response to immunotherapy.
Scientists at Northwestern Medicine have developed new techniques in human blood to pave potential paths towards a HIV cure.
A recent study has shown that antiretroviral therapy timing impacts the animal version of HIV and latent tuberculosis.
A new potential mRNA vaccine that delivers instructions for making two key HIV proteins has been tested in mice and rhesus macaques.
In this article, Patrick Kendall, Scientific Advisor for Artelo Biosciences, outlines why future treatment of cancer anorexia-cachexia syndrome may lie with drugs in development offering a mechanistic approach.
The new nanoparticle adjuvant improved antibody production following vaccination against HIV, diphtheria and influenza in mouse models.